Medically reviewed by Mary Choy, PharmDMedically reviewed by Mary Choy, PharmD Overactive ... relax the bladder muscles and ...

For the first time in over 25 years (since the approval of oxybutynin in 1972), better medications are available for the overactive bladder. With the recent approval of tolterodine and oxybutynin ...

Prescription medications can ease overactive bladder symptoms. Supplements for overactive bladder may help, although little robust evidence supports their value. An overactive bladder (OAB ...

Drugs to treat overactive bladder don't work very well, according to a recent CR Best Buy Drugs analysis. Studies have found that only a small proportion of people get full relief of their ...

The bladder ... medications are advised to consult their healthcare provider before taking this supplement. Zinc is ...

Botox is a prescription drug that’s used to treat certain bladder problems, such as overactive bladder (OAB) in adults. For certain bladder problems, Botox may also be prescribed to children ...

Your health care providers can help you discover the treatments best for you. Overactive bladder can be triggered, or irritated, by many things, from medications to a simple cola. It's a great ...

Gemtesa (vibegron) is a prescription drug used to treat symptoms of overactive bladder (OAB). Gemtesa can cause side effects that range from mild to serious. Examples include headache, nausea ...

Somewhere between 15 and 20 million people are affected by overactive bladder and/or incontinence ... Is there a way to stop it? Without medication? So what I always start with in the clinical ...

The Overactive Bladder Innovative Therapy Trial (ORBIT) was a randomized multicenter trial that compared PTNS to extended release tolterodine, a drug commonly used for the treatment of overactive ...

One in six adults have bladder control problems. It can disrupt sleep or cause accidents, lead to social isolation and depression and affects women more than men.

This amount can be increased provided the drug meets certain milestones. Royalties of both fesoterodine and Pfizer's Detrol product line for treatment of overactive bladder will be paid to Schwarz.